| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |